$SNPS

Synopsys signs chip deal with AWS worth over $1bn

Synopsys and Amazon Web Services (AWS) signed a multi-year deal worth over $1bn for semiconductor design IP licenses. Synopsys' IP licensing unit generated $1.75bn in revenue last fiscal year. AWS designs its own chips, including Graviton processors and Trainium accelerators. The partnership also includes Synopsys adopting AWS services for AI applications.

Original reporting
Published Sep 30, 2026, 5:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 5:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS · $AMZN
Relevance
9/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The partnership may accelerate AWS's chip roadmap while providing Synopsys with a marquee customer, enhancing both companies' growth narratives.

02

Market read

A high‑value licensing deal that could lift Synopsys shares and influence the broader chip design ecosystem.

03

What to watch

Potential integration challenges and the competitive response from Arm or other IP providers.

Relevance 9/10Novelty 9/10Timing: immediate

Background

AWS is expanding its custom silicon portfolio (Graviton, Trainium) and seeks advanced IP to accelerate development.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys signed a multi-year IP licensing deal with AWS worth over $1bn.

Expected impact

likely upside as investors price in increased licensing revenue

Evidence & confidence

Deal size exceeds $1bn and expands Synopsys' addressable market, which should boost earnings outlook.

$AMZNNeutralHigh confidence
Context

Amazon's AWS unit entered a $1bn licensing agreement with Synopsys.

Expected impact

likely neutral to slight downside as licensing expense is priced in

Evidence & confidence

The cost is sizable but aligns with AWS's long‑term chip development goals; impact on Amazon's broader earnings is limited.

Market effects

Strengthens the semiconductor IP and EDA sector, potentially lifting peers like Cadence and Mentor.

Boosts U.S. technology and cloud computing equities.

Highlights growing collaboration between cloud providers and chip designers worldwide.

Counterpoint

The licensing fees could compress AWS margins, and the deal may signal Synopsys' reliance on a few large customers.

Key entities

  • Synopsys

    Provider of semiconductor design IP and EDA tools.

  • Amazon Web Services

    AWS's cloud computing division developing custom processors.

Related articles

$SNPSHighAI 9/10

Synopsys stock analysis: what does today’s news tell investors?

Synopsys Inc (SNPS) stock rose 4.97% to $435.70 after announcing a $1B+ multi-year deal with Amazon.com (AMZN) for silicon IP licensing. The deal introduces a new license-plus-royalty model. Additionally, Synopsys partnered with OpenAI to develop GPT-Synopsys for semiconductor design. CEO Sassine Ghazi raised FY2027 revenue growth guidance to 15%, above analyst consensus of 11.19%.

$SNPSLow

OpenAI and Synopsys Announce GPT-Synopsys: Frontier Intelligence to Revolutionize Chip Design

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, a specialized AI model for chip design. The collaboration combines OpenAI's AI capabilities with Synopsys' EDA tools. The agreement includes revenue sharing and joint go-to-market initiatives. Synopsys will license its EDA tools to OpenAI for this project. The partnership aims to accelerate semiconductor innovation and improve chip design processes.

$MSFTMedAI 8/10

FTC opens probe into Anthropic, OpenAI over AI agent risks

The FTC is investigating Anthropic, OpenAI, and other AI labs over risks posed by rogue AI agents, following recent incidents. The agency will compel testimony from executives and research groups. Anthropic and OpenAI have reported thousands of security incidents involving their models. Both companies face regulatory and legal risks, with Anthropic warning of significant legal risks in its IPO prospectus.